Press "Enter" to skip to content

Antimalarial drug touted by President Trump is linked to increased risk of death in coronavirus patients, study says

Antimalarial drug touted by President Trump is linked to increased risk of death in coronavirus patients, study says

Lancet slams use of hydrochloprophine for Covid-19

A study of 96,000 hospitalized coronavirus patients on six continents found that those who received an  antimalarial drug promoted by President Trump as a “game changer” in the  fight against the virus had a significantly higher risk of death  compared with those who did not.

People  treated with hydroxychloroquine, or the closely related drug  chloroquine, were also more likely to develop a type of irregular heart  rhythm, or arrhythmia, that can lead to sudden cardiac death, it  concluded.

Source: Antimalarial drug touted by President Trump is linked to increased risk of death in coronavirus patients, study says

Facebook Comments

Disqus Comments

Specify a Disqus shortname at Social Comments options page in admin panel